ECCO Topical Review on Predictive Models on Inflammatory Bowel Disease Disease Course and Treatment Response - Summary - MDSpire

ECCO Topical Review on Predictive Models on Inflammatory Bowel Disease Disease Course and Treatment Response

  • By

  • Julien Kirchgesner

  • Bram Verstockt

  • Michel Adamina

  • Kristine H Allin

  • Mariangela Allocca

  • Arno R Bourgonje

  • Johan Burisch

  • Glen Doherty

  • Parambir S Dulai

  • Alaa El-Hussuna

  • Ravi Misra

  • Nurulamin Noor

  • Valérie Pittet

  • Nick Powell

  • Iago Rodríguez-Lago

  • Sophie Restellini

  • May 4, 2025

  • 0 min

Share

Objective:

To examine existing predictive models for inflammatory bowel disease (IBD) progression and treatment response, assess their relevance, and discuss specific barriers to clinical implementation, such as validation and consistency issues.

Key Findings:
  • Fourteen practice positions and two perspective points were developed regarding predictive models for IBD.
  • Common predictors of poor disease course include younger age at diagnosis, male gender, and elevated CRP levels.
  • Methodological barriers to the implementation of predictive models were identified, including validation issues and lack of standardization.
Interpretation:

The review highlights the urgent need for improved methodologies in developing predictive models for IBD and emphasizes the critical importance of integrating relevant biomarkers into clinical practice.

Limitations:
  • Current predictive models lack validation and consistent methodology, which undermines their reliability.
  • Many identified biomarkers are not yet utilized in clinical settings, limiting their potential impact on treatment decisions.
Conclusion:

The review provides guidance for future predictive models in IBD, aiming to enhance their clinical applicability and improve patient outcomes.

Original Source(s)

ECCO Topical Review on Predictive Models on Inflammatory Bowel Disease Disease Course and Treatment Response

  • by Julien Kirchgesner, Bram Verstockt, Michel Adamina, Kristine H Allin, Mariangela Allocca, Arno R Bourgonje, Johan Burisch, Glen Doherty, Parambir S Dulai, Alaa El-Hussuna, Ravi Misra, Nurulamin Noor, Valérie Pittet, Nick Powell, Iago Rodríguez-Lago, Sophie Restellini

  • May 4, 2025

Related Content

The role of a multidisciplinary approach in the early and differential diagnosis of inflammatory bowel disease–related spondyloarthritis: insights from a cross-sectional study

Refining Vancomycin Use in Early CDI

A modified dosing approach could reshape recurrence prevention strategies.

Medical Oddities: Essential Oil, Deadly Consequences

A cabinet mix-up, a chatty heart, a violet catheter bag, stressed kids, and tea that won’t save the brain—just another week.